News

Activities to focus on MDRNA's proprietary RNAi drug discovery platform UsiRNA constructs and DiLA2 delivery system.

Lawrence Brody to lead group recognized for applying Genome Science to advance studies of health and disease.

New study offers surprising new clues into the genomic complexity of the giant Mimivirus, the largest known virus in the world.

The Company has announced positive test results from a series of animal experiments carried out at a prominent Canadian cancer research facility.

Prosensa’s second clinical candidate for treatment of Duchenne Muscular Dystrophy.

The webinars will consist of scientific presentations from industry experts focused on a broad range of drug development activities.

Researchers have discovered a fifth genetic mutation associated with typical motor neurone disease, or amyotrophic lateral sclerosis, that has a similar pathological effect to certain genetic mutations revealed in earlier studies.

Newly found gene called DAF- 16 is involved in determining the rate of ageing and average lifespan of the laboratory worm C. elegans.

The Company has joined a multi-partner European research program dedicated to improving the diagnosis and treatment of chronic kidney disease.

Scientists have made a major breakthrough in identifying new treatments for a fatal disease which infects tens of thousands of Africans each year.